Quality of life and health status with zoledronic acid and generic alendronate—a secondary analysis of the Rapid Onset and Sustained Efficacy (ROSE) study in postmenopausal women with low bone mass
8 auth. P. Hadji, V. Ziller, D. Gamerdinger, W. Spieler, K. Articus, M. Baier, ... R. Moericke, P. Kann